Education
About Us
Working with TipRanks
Follow Us
Moleculin Biotech (MBRX)
NASDAQ:MBRX
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | - | - | - | - | - |
| Operating Income | $ -29.63M | $ -30.64M | $ -22.97M | $ -19.74M | $ -17.52M |
| EBITDA | $ -29.50M | $ -30.51M | $ -22.80M | $ -19.54M | $ -13.25M |
| Net Income | $ -29.77M | $ -29.02M | $ -15.89M | $ -17.36M | $ -13.21M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 38.22M | $ 57.42M | $ 84.09M | $ 29.03M | $ 25.23M |
| Total Debt | $ 474.00K | $ 335.00K | $ 63.00K | $ 159.00K | $ 276.00K |
| Net Debt | $ -23.08M | $ -42.81M | $ -70.84M | $ -15.01M | $ -10.46M |
| Total Liabilities | $ 12.14M | $ 5.23M | $ 5.10M | $ 11.27M | $ 9.70M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -24.23M | $ -27.71M | $ -18.97M | $ -18.14M | $ -17.25M |
| Operating Cash Flow | $ -24.10M | $ -27.64M | $ -18.95M | $ -17.77M | $ -17.20M |
| Investing Cash Flow | |||||
| Financing Cash Flow |